China Experimental Fast Reactor
China Experimental Fast Reactor (CEFR)[edit]

The China Experimental Fast Reactor (CEFR) is a nuclear reactor located in China. It is a fast neutron reactor and serves as a prototype for future fast breeder reactors in China. The CEFR is part of China's efforts to develop advanced nuclear technology and to establish a closed nuclear fuel cycle.
Design and Development[edit]
The CEFR is a sodium-cooled fast reactor with a thermal power output of 65 MW and an electrical output of 20 MW. It was designed to test the technology and components necessary for larger fast reactors. The reactor uses mixed oxide fuel (MOX), which is a blend of plutonium and uranium.
The development of the CEFR began in the 1990s, with construction starting in 2000. The reactor achieved its first criticality in 2010 and was connected to the grid in 2011. The CEFR is operated by the China Institute of Atomic Energy (CIAE).
Objectives[edit]
The primary objectives of the CEFR are to:
- Demonstrate the feasibility of fast reactor technology in China.
- Provide a platform for research and development of fast reactor technology.
- Test the performance of sodium coolant systems and other components.
- Contribute to the development of a closed nuclear fuel cycle by using MOX fuel.
Significance[edit]
The CEFR is significant for several reasons:
- It represents China's commitment to developing advanced nuclear technology.
- It is a step towards achieving energy security and reducing reliance on fossil fuels.
- It provides valuable data and experience for the design and construction of future fast reactors, such as the planned China Fast Reactor 600 (CFR-600).
Challenges[edit]
Operating a fast reactor like the CEFR presents several challenges:
- Managing the sodium coolant, which is highly reactive with water and air.
- Ensuring the safety and reliability of the reactor systems.
- Developing and handling MOX fuel, which contains plutonium.
Future Prospects[edit]
The success of the CEFR is expected to pave the way for larger commercial fast reactors in China. The experience gained from the CEFR will inform the design and operation of the CFR-600 and other future reactors. These reactors are part of China's strategy to establish a sustainable and secure energy supply.
Related Pages[edit]
Ad. Transform your life with W8MD's Budget GLP-1 injections from $75


W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Weight loss injections in NYC (generic and brand names):
- Zepbound / Mounjaro, Wegovy / Ozempic, Saxenda
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $75 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointmentsNYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian